Hyderabad, India -- (SBWIRE) -- 02/28/2018 -- The report "Anti - Fungal Drugs Market by Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Other Drugs), by Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis, Other Therapeutic Indications), by Application (Powders, Ointments, Drugs, Pastes), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)", The Anti-Fungal Drugs market is expected to reach USD 14.56 Billion by 2021 from an estimated USD 12.15 Billion in 2016, at a CAGR of 3.68%. The key factors such as growing awareness about fungal infections and increased government and corporate funding in the industry are driving the growth of this market.

Browse through 218 Pages and in-depth TOC on "Anti – Fungal Drugs Market "
https://www.marketdataforecast.com/market-reports/global-anti-fungal-drugs-market-242/
Early buyers will receive 10% customization on reports.

By Drug type, the Azoles anti – fungal drugs segment accounted for the largest share of the market in 2016.

On the basis of Drug type, the Anti – Fungal Drugs market has been segmented into Echinocandins, Azoles, Polyenes, Allylamines and Other Drugs. In 2016, Azoles antifungal drug market is the largest segment of the market. The share in this market is seconded by echinocandins antifungal drug market. The growth in this market segment is mainly driven by the rising popularity of over-the-counter antifungal drugs for dermal infections.
By Therapeutic Indications, the Dermatophytosis accounted for the largest share of the market in 2016.

Customized Report: https://www.marketdataforecast.com/market-reports/global-anti-fungal-drugs-market-242/customize-report

On the basis of Therapeutic Indications, the anti – fungal drugs market has been segmented into Aspergillosis, Dermatophytosis, Candidiasis, Other Therapeutic Indications. In 2016, the Dermatophytosis is expected to account for the largest share of the global Genomics market. The Candidiasis segment on the other hand, is expected to be the fastest-growing segment during the forecast period. In addition, invasive pulmonary aspergillosis is the major cause of death in patients with bone - marrow transplantation. The rising need to curb these conditions is the factor expected to propel the industry growth in the coming years.

By application, the drugs segment accounted for the largest share of the market in 2016.
On the basis of application, the anti – fungal drugs market has been segmented into Powders, Ointments, Drugs, Pastes. In 2016, the drugs segment is expected to account for the largest share of the global anti – fungal drugs market. It is also expected to be the fastest-growing segment during the forecast period. A wide range of fungicidal preparations, such as creams, sprays, tablets, and injections, are available and increasing adoption of these products is predicted to drive the demand during the forecast period.

Request Sample: https://www.marketdataforecast.com/market-reports/global-anti-fungal-drugs-market-242/request-sample

North America accounted for the largest share of the Genomics market in 2016, followed by Europe. The market in Asia-Pacific is the fastest growing market followed by Latin America. The presence of large populations, and increased number of healthcare establishments and rise in clinical needs relating to fungal diseases are anticipated to provide a potential growth platform to this region for pharmaceutical players.

The various players in the Anti – Fungal Drugs market include Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories among others.

About MarketDataForecast™
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.

Related Link:
https://www.marketdataforecast.com/market-reports/global-anticoccidial-drugs-market-13/

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626